FindMyKOL

Top experts by indication / Oncology

Most active experts in Hodgkin Disease

2026 edition, data as of October 27, 2026

298 key opinion leaders in the directory are tagged to Hodgkin Disease. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.

Most registered trials

Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 298 of the 298 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.

#Experttrials
1Ajay GopalUniversity of Washington School of Medicine, WA17 trials
2Alex HerreraCity of Hope, CA14 trials
3Brenda SandmaierFred Hutchinson Cancer Center, WA12 trials
4Anas YounesNY11 trials
5Mitchell CairoNew York Medical College, NY10 trials
6Ryotaro NakamuraCity of Hope, CA9 trials
7Alison MoskowitzMemorial Sloan Kettering Cancer Center, NY9 trials
8Helen HeslopBaylor College of Medicine, TX8 trials
9Julie VoseUniversity of Nebraska Medical Center, NE7 trials
10David MaloneyFred Hutchinson Cancer Center, WA7 trials
11Thomas WitzigMayo Clinic, MN7 trials
12Veronika BachanovaUniversity of Minnesota Medical School, MN6 trials
13Jeremy AbramsonMassachusetts General Hospital, MA6 trials
14Neal FlomenbergThomas Jefferson University, PA5 trials
15Brandon TriplettSt. Jude Children's Research Hospital, TN5 trials
16Nancy BartlettWashington University School of Medicine, MO5 trials
17Ranjana AdvaniStanford University School of Medicine, CA5 trials
18Catherine DiefenbachNYU Langone Health, NY5 trials
19David AviganDana-Farber Cancer Institute, MA5 trials
20Stephen AnsellMayo Clinic, MN4 trials
21Owen O'ConnorNY4 trials
22Nirav ShahWI4 trials
23Claudio BrunsteinMN4 trials
24Jane WinterIL4 trials
25Grzegorz NowakowskiMayo Clinic, MN4 trials

Most cited

Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 88 of the 298 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.

#Expertcitations
1John DipersioWashington University School of Medicine, MO98,282 citations
2Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX77,241 citations
3Thomas WitzigMayo Clinic, MN62,686 citations
4Julie VoseUniversity of Nebraska Medical Center, NE59,133 citations
5Malcolm BrennerBaylor College of Medicine, TX59,020 citations
6Mary HorowitzMedical College of Wisconsin, WI57,794 citations
7Ian FlinnTennessee Oncology, TN55,739 citations
8David MaloneyFred Hutchinson Cancer Center, WA54,034 citations
9Stephen AnsellMayo Clinic, MN52,585 citations
10Hillard LazarusCase Western Reserve University School of Medicine, OH50,317 citations
11Bruce ChesonThe Center for Cancer and Blood Disorders, MD49,627 citations
12Ranjana AdvaniStanford University School of Medicine, CA48,943 citations
13Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX48,319 citations
14Nancy BartlettWashington University School of Medicine, MO48,210 citations
15Helen HeslopBaylor College of Medicine, TX43,332 citations
16Corey CutlerDana-Farber Cancer Institute, MA42,105 citations
17Yi LinMayo Clinic, MN40,137 citations
18Philippe ArmandMayo Clinic, MN38,160 citations
19Brenda SandmaierFred Hutchinson Cancer Center, WA36,879 citations
20Joanne KurtzbergDuke University Medical Center, NC35,382 citations
21Patricia LorussoYale School of Medicine, MI34,992 citations
22Stephen SchusterUniversity of Pennsylvania, PA33,743 citations
23John LeonardNYU Langone Health, NY32,192 citations
24Ronald GressNational Cancer Institute (NIH), MD31,095 citations
25Jason WestinThe University of Texas MD Anderson Cancer Center, TX30,280 citations

Most NIH awards

NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 75 of the 298 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.

#Expertawards
1Ronald LevyCA22 awards
2Richard AmbinderJohns Hopkins University School of Medicine, MD19 awards
3John DipersioWashington University School of Medicine, MO15 awards
4Edmund WallerEmory University, GA13 awards
5Malcolm BrennerBaylor College of Medicine, TX12 awards
6Brenda SandmaierFred Hutchinson Cancer Center, WA11 awards
7Helen HeslopBaylor College of Medicine, TX9 awards
8Mitchell CairoNew York Medical College, NY9 awards
9Mary HorowitzMedical College of Wisconsin, WI8 awards
10Carl AllenTX7 awards
11Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX7 awards
12David AviganDana-Farber Cancer Institute, MA7 awards
13Jennifer WoyachThe Ohio State University, OH7 awards
14Joanne KurtzbergDuke University Medical Center, NC7 awards
15Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX6 awards
16Lawrence KaplanSan Francisco General Hospital, CA6 awards
17Saro ArmenianCity of Hope, CA6 awards
18Thomas WitzigMayo Clinic, MN6 awards
19Nancy BartlettWashington University School of Medicine, MO5 awards
20Hillard LazarusCase Western Reserve University School of Medicine, OH5 awards
21Ajay GopalUniversity of Washington School of Medicine, WA5 awards
22Yi LinMayo Clinic, MN5 awards
23Stephen AnsellMayo Clinic, MN4 awards
24David McDermottBeth Israel Deaconess Medical Center, MA4 awards
25Sandra HorningCA4 awards

Most congress contributions

Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 57 of the 298 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.

#Expertcontributions
1Patricia LorussoYale School of Medicine, MI272 contributions
2Ian FlinnTennessee Oncology, TN242 contributions
3Thomas WitzigMayo Clinic, MN240 contributions
4Yi LinMayo Clinic, MN226 contributions
5Stephen SchusterUniversity of Pennsylvania, PA224 contributions
6Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX217 contributions
7Brad KahlWashington University School of Medicine in St. Louis, MO208 contributions
8Partow KebriaeiThe University of Texas MD Anderson Cancer Center, TX202 contributions
9Mazyar ShadmanFred Hutchinson Cancer Center, WA199 contributions
10Jason WestinThe University of Texas MD Anderson Cancer Center, TX198 contributions
11Jennifer WoyachThe Ohio State University, OH176 contributions
12John DipersioWashington University School of Medicine, MO171 contributions
13Jonathon CohenEmory University, GA169 contributions
14Ranjana AdvaniStanford University School of Medicine, CA160 contributions
15John LeonardNYU Langone Health, NY159 contributions
16Ibrahim AldossCity of Hope, CA151 contributions
17Paolo CaimiCleveland Clinic, OH139 contributions
18Alison MoskowitzMemorial Sloan Kettering Cancer Center, NY137 contributions
19Geoffrey UyWashington University School of Medicine, MO130 contributions
20David MaloneyFred Hutchinson Cancer Center, WA127 contributions
21Ryotaro NakamuraCity of Hope, CA125 contributions
22Edmund WallerEmory University, GA121 contributions
23Julie VoseUniversity of Nebraska Medical Center, NE115 contributions
24Kami MaddocksThe Ohio State University, OH111 contributions
25Philippe ArmandMayo Clinic, MN111 contributions

Emerging

6 of the 298 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.

Rafael BejarUniversity of California, San Diego, CA
Sharon CastellinoEmory University, GA
Douglas HawkinsSeattle Children's Hospital, WA
Bilal OmerBaylor College of Medicine, TX
Sandra SilbermanNC
Dan VoglUniversity of Pennsylvania, PA

How these tables are computed

The cohort is every profile in the directory tagged to Hodgkin Disease, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.

Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.

The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.

What is deliberately absent

Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.

Filter, sort and open every Hodgkin Disease profile in the directory